CLN3 deficiency leads to neurological and metabolic perturbations during early development
Life Science Alliance · 2024
DOI: 10.26508/lsa.202302057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2024. Verfasst von Ursula Heins-Marroquin und 17 weiteren Autor:innen. Beteiligte Einrichtung: Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg ursula.heins-marroquin@uni.lu. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Neuronal Ceroid-Lipofuscinoses. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, Fonds National de la Recherche Luxembourg.
Abstract (Originalsprache)
Juvenile neuronal ceroid lipofuscinosis (or Batten disease) is an autosomal recessive, rare neurodegenerative disorder that affects mainly children above the age of 5 yr and is most commonly caused by mutations in the highly conserved CLN3 gene. Here, we generated cln3 morphants and stable mutant lines in zebrafish. Although neither morphant nor mutant cln3 larvae showed any obvious developmental or morphological defects, behavioral phenotyping of the mutant larvae revealed hyposensitivity to abrupt light changes and hypersensitivity to pro-convulsive drugs. Importantly, in-depth metabolomics and lipidomics analyses revealed significant accumulation of several glycerophosphodiesters (GPDs) and cholesteryl esters, and a global decrease in bis(monoacylglycero)phosphate species, two of which (GPDs and bis(monoacylglycero)phosphates) were previously proposed as potential biomarkers for CLN3 disease based on independent studies in other organisms. We could also demonstrate GPD accumulation in human-induced pluripotent stem cell–derived cerebral organoids carrying a pathogenic variant for CLN3 . Our models revealed that GPDs accumulate at very early stages of life in the absence of functional CLN3 and highlight glycerophosphoinositol and BMP as promising biomarker candidates for pre-symptomatic CLN3 disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg ursula.heins-marroquin@uni.lu.
- Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
- Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA.
- Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany.
- Institut d'Investigació Sanitària Pere Virgili, Tarragona, Spain.
- Biosfer Teslab SL, Reus, Spain.
ORCID-Profile: Ursula Heins-Marroquin, Randolph R Singh, Simon Perathoner, Floriane Gavotto, Melanie Meyer, Anaïs Carpentier, Jens C Schwamborn, Emma L Schymanski, Carole L Linster
Förderung
- NIEHS NIH HHS
- Fonds National de la Recherche Luxembourg
Zitieren
APA
Heins-Marroquin, U., Singh, R. R., Perathoner, S., Gavotto, F., Merino Ruiz, C., Patraskaki, M., Gomez-Giro, G., Kleine Borgmann, F., Meyer, M., Carpentier, A., Warmoes, M. O., Jäger, C., Mittelbronn, M., Schwamborn, J. C., Cordero-Maldonado, M. L., Crawford, A. D., Schymanski, E. L., & Linster, C. L. (2024). CLN3 deficiency leads to neurological and metabolic perturbations during early development. Life Science Alliance. https://doi.org/10.26508/lsa.202302057
Vancouver
Heins-Marroquin U, Singh RR, Perathoner S, Gavotto F, Merino Ruiz C, Patraskaki M, et al. CLN3 deficiency leads to neurological and metabolic perturbations during early development. Life Science Alliance. 2024. doi:10.26508/lsa.202302057
BibTeX
@article{HeinsMarroquin2024,
author = {Heins-Marroquin, Ursula and Singh, Randolph R and Perathoner, Simon and Gavotto, Floriane and Merino Ruiz, Carla and Patraskaki, Myrto and Gomez-Giro, Gemma and Kleine Borgmann, Felix and Meyer, Melanie and Carpentier, Anaïs and Warmoes, Marc O and Jäger, Christian and Mittelbronn, Michel and Schwamborn, Jens C and Cordero-Maldonado, Maria Lorena and Crawford, Alexander D and Schymanski, Emma L and Linster, Carole L},
title = {CLN3 deficiency leads to neurological and metabolic perturbations during early development},
journal = {Life Science Alliance},
year = {2024},
doi = {10.26508/lsa.202302057}
}
EUVIMED